Table 5.
Term | Coefficient | ta | P valuea | |
---|---|---|---|---|
IgE b | Intercept | −1.31 ± 0.31 | −4.28 | <0.001 |
Time (Day 21 p.s.i.) | 0.513 ± 0.194 | 2.65 | <0.01 | |
Secondary dose (30 or 750 iL3s)c | 0.639 ± 0.206 | 3.11 | <0.01 | |
Primary spp. (N. brasiliensis) | 0.600 ± 0.314 | 1.91 | 0.06 | |
Primary spp. (S. venezuelensis) | 0.574 ± 0.314 | 1.83 | 0.07 | |
Primary spp. (S. ratti, 30 iL3s) | 0.866 ± 0.363 | 2.39 | <0.05 | |
Primary spp. (S. ratti, 750 iL3s) | 1.18 ± 0.36 | 3.24 | <0.01 | |
IgG1 d | Intercept | −0.830 ± 0.133 | −6.24 | - |
Time (Day 21 p.s.i.) | 0.250 ± 0.189 | 1.32 | 0.19 | |
Secondary dose (30 iL3s) | −0.043 ± 0.177 | −0.24 | 0.81 | |
Secondary dose (750 iL3s) | 0.019 ± 0.177 | 0.11 | 0.92 | |
Primary spp. S. ratti (30 iL3s) | 0.644 ± 0.209 | 3.08 | <0.01 | |
Primary spp. S. ratti (750 iL3s) | 2.19 ± 0.21 | 10.5 | <0.001 | |
Time × Secondary dose (30 iL3s) | 0.822 ± 0.250 | 3.29 | <0.01 | |
Time × Secondary dose (750 iL3s) | 1.55 ± 0.25 | 6.13 | <0.001 | |
Time × Primary spp. S. ratti (30 iL3s) | −0.116 ± 0.309 | −0.38 | 0.71 | |
Time × Primary spp. S. ratti (750 iL3s) | −0.849 ± 0.296 | −2.87 | <0.01 | |
RMCPII e | Intercept | −1.55 ± 0.34 | −4.58 | - |
Secondary dose (30 or 750 iL3s)c | 0.902 ± 0.182 | 4.97 | <0.001 | |
Time (Day 21 p.s.i.) | 0.564 ± 0.469 | 1.2 | 0.23 | |
Primary spp. (N. brasiliensis) | 1.45 ± 0.39 | 3.75 | <0.001 | |
Primary spp. (S. venezuelensis) | 1.14 ± 0.40 | 2.95 | <0.01 | |
Primary spp. (S. ratti) | 1.79 ± 0.39 | 4.63 | <0.001 | |
Time × Primary spp. (N. brasiliensis) | −1.56 ± 0.56 | −2.76 | <0.01 | |
Time × Primary spp. (S. venezuelensis) | −1.19 ± 0.56 | −2.1 | <0.05 | |
Time × Primary spp. (S. ratti) | −1.44 ± 0.56 | −2.55 | <0.05 | |
IL4 MLN f | Intercept | −1.27 ± 0.27 | −4.73 | - |
Secondary dose (30 iL3s) | 0.969 ± 0.295 | 3.28 | <0.01 | |
Secondary dose (750 iL3s) | 1.56 ± 0.30 | 5.30 | <0.001 | |
Primary spp. S. ratti (30 or 750 iL3s)g | 0.646 ± 0.256 | 2.53 | <0.05 | |
IL13 MLN h | Intercept | −0.315 ± 0.242 | −1.30 | - |
Time (Day 21 p.s.i.) | −0.856 ± 0.255 | −3.36 | <0.01 | |
Secondary dose (30 or 750 iL3s)c | 1.27 ± 0.26 | 4.88 | <0.001 | |
IL13 spleen i | Intercept | −0.97 ± 0.21 | −4.63 | - |
Secondary dose (30 or 750 iL3s)c | 1.46 ± 0.26 | 5.67 | <0.001 | |
IFNγ MLNj | Intercept | −0.529 ± 0.318 | −1.67 | - |
Time (Day 21 p.s.i.) | 0.983 ± 0.259 | 3.79 | <0.001 | |
Primary spp. S. ratti (30 or 750 iL3s)g | −0.628 ± 0.275 | −2.28 | <0.05 | |
Secondary dose (30 or 750 iL3s)c | 0.685 ± 0.275 | 2.49 | <0.05 |
Significance of individual terms are presented as estimates against a t distribution. F tests from deletion tests are presented in the text.
2 × log-likelihood = −211.92 with 78 residual degrees of freedom
Factor levels for secondary dose were grouped such that animals receiving a dose of 0 were compared with those receiving either 30 or 750 S. ratti iL3s.
2 × log-likelihood = −98.70 with 73 residual degrees of freedom
2 × log-likelihood = −183.40 with 74 residual degrees of freedom
2 × log-likelihood = −74.56 with 32 residual degrees of freedom
Factor levels for primary dose were grouped such that animals receiving either PBS, N. brasiliensis or S. venezuelensis were compared with those receiving 30 or 750 S. ratti iL3s as a primary infection.
2 × log-likelihood = −65.88 with 29 residual degrees of freedom
2 × log-likelihood = −77.16 with 34 residual degrees of freedom
2 × log-likelihood = −79.89 with 32 residual degrees of freedom